Complex pharmacology of natural cannabinoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors

Life Sciences

Volumn 63, Issue 1, 1998, Pages PL1-

  Petitet, François ^a   Jeantaud, Bernadette ^a   Reibaud, Michel ^a   Imperato, Assunta ^a   Dubroeucq, Marie Christine ^a  

^a SANOFI   (France)

Author keywords

Cannabidiol; Cannabinoid; Cannabinol; 35S GTP S binding; 9 tetrahydrocannabinol

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABIDIOL; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOL; CANNABIS; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); TETRAHYDROCANNABINOL;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CEREBELLUM; MALE; NONHUMAN; RAT;

ANIMALIA; CANNABIS; CANNABIS SATIVA;

EID: 0032577340     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00238-0     Document Type: Article

References (23)

1. 1. Y. GAONI and R. MECHOULAM, 86 1646-1647 (1964).
2. 2. A.C. HOWLETT and R.M. FLEMING, Mol. Pharmacol. 26 532-538 (1984).
3. 3. M.P. CAULFIELD and D.A. BROWN, Br. J. Pharmacol 106 231-232 (1992).
4. 4. M. RINALDI-CARMONA, F. BARTH, M. HEAULME, D. SHIRE, B. CALANDRA, C. CONGY, S. MARTINEZ, J. MARUANI, G. NELIAT, D. CAPUT, P. FERRARA, P. SOUBRIE, J.-C. BRELIERE and G. LE FUR, FEBS Lett. 350 240-244 (1994).
5. 5. D.R. COMPTON, M.D. ACETO, J. LOWE and B.R MARTIN, J Pharmacol Exp Ther, 277 586-594 (1996).
6. 6. M. BAYEWITCH, T. AVIDOR-REISS, R. LEVY, J. BARG, R. MECHOULAM and Z. VOGEL, FEBS Lett. 375 143-147 (1995).
7. 7. M. BAYEWITCH, M-H. RHEE, T. AVIDOR-REISS, A. BREUER, R. MECHOULAM and Z. VOGEL, J. Biol. Chem. 271 9902-9905 (1996).
8. 8. L.J. SIM, R.E. HAMPSON, S.A. DEADWYLER and S.R. CHILDERS, J. Neurosci. 16 8057-8066 (1996).
9. 9. T.H. BURKEY, R.M. QUOCK, P. CONSROE, W.R. ROESKE and H.I. YAMAMURA, Eur. J. Pharmacol. 323 R3-R4 (1997).
10. 10. S. MUNRO, K.L. THOMAS and M. ABU-SHAAR, Nature 365 61-65 (1993).
11. 11. P. CONSROE and S.R. SNIDER, Cannabinoids as therapeutic agents, R. Mechoulam (Ed), 21-70, CRC Press, (1986).
12. 12. P. CONSROE, R.E. MUSTY and L.H. CONTI Marihuana: an international research report, G. Chester, P. Consroe and R.E. Musty (Eds), 141-146, Australian governement publishing Service, Canberra (1988).
13. 13. R.E. MUSTY, L.H. CONTI and R. MECHOULAM Marihuana 84, D. Harvey (Ed), 713-719, (1985).
14. 14. I.G. KARNIOL and E.A. CARLINI, Psychopharmacol. (Berl.) 33 53-70 (1970).
15. 15. A. LORENZEN, M. FUSS, H. VOGT and U. SCHWABE, Mol. Pharmacol. 44 115-123 (1993).
16. 16. J.F. TRAYNOR and S.R. NAHORSKI, Mol. Pharmacol. 47 848-854 (1995).
17. 17. L.J. SIM, D.E. SELLEY and S.R. CHILDERS, Proc. Natl. Acad. Sci. U.S.A. 92 7242-7246 (1995).
18. 18. D.E. SELLEY, S. STARK, L.J. SIM and S.R. CHILDERS, Life Sci. 59 659-668 (1996).
19. 19. F. PETITET, B. JEANTAUD, M. CAPET and A. DOBLE, Biochem. Pharmacol. 54 1267-1270 (1997).
20. 20. J.E. KUSTER, J.I. STEVENSON, S.J. WARD, T.E. D'AMBRA and D.A. HAYCOCK, J. Pharmacol. Exp. Ther. 264 1352-1363 (1993).
21. 21. B.R. MARTIN, Pharmacol. Rev. 38 45-74 (1986).
22. 22. I.G. KARNIOL, I. SHIRAKAWA, N. KASINSKI, A. PFEFERMAN and E.A. CARLINI, Eur. J. Pharmacol. 28 172-177 (1974).
23. 23. A.W. ZUARDI, E. FINKELFARB, O.F. BUENO, R.E. MUSTY and I.G. Karniol, Arch. Int. Pharmacodyn. Ther. 249 137-146 (1981).